Charles River Laboratories International Inc.

NYSE:CRL   3:59:59 PM EDT
322.59
-6.48 (-1.97%)
4:00:00 PM EDT: $323.05 +0.46 (+0.14%)
Other Pre-Announcement

Charles River Laboratories Reports Q1 Non GAAP EPS Of $2.53

Published: 05/04/2021 11:35 GMT
Charles River Laboratories International Inc. (CRL) - Charles River Laboratories Announces First-quarter 2021 Results.
Q1 Non-GAAP Earnings per Share $2.53.
Q1 GAAP Earnings per Share $1.20.
Q1 Revenue Rose 16.6 Percent to $824.6 Million.
Updates 2021 Guidance.
Sees 2021 Reported Revenue Growth of 19% - 21%.
Sees 2021 Organic Revenue Growth of 12% - 14%.
2021 GAAP EPS Estimate of $5.95 - $6.20.
2021 Non-GAAP EPS Estimate of $9.75 - $10.00.
Q1 Earnings per Share View $2.19, Revenue View $798.2 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Earnings per Share View $9.24, Revenue View $3.38 Billion -- Refinitiv Ibes Data (analyst estimates).